BFLY
Butterfly Network, Inc.
BFLY's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over BFLY overall, supported by lower modeled downside and stronger fundamentals.
BFLY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
BFLY's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
BFLY PE Valuation
BFLY has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
BFLY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BFLY's losses to shrink, with revenue growing.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
BFLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.21 | +$0.13 |
| Q2 2026 | -$0.29 | $0.00 |
| Q1 2026 | -$0.30 | $0.00 |
| Q4 2025 | -$0.31 | +$0.03 |
| Q3 2025 | -$0.34 | +$0.12 |
| Q2 2025 | -$0.29 | +$0.22 |
| Q1 2025 | -$0.30 | +$0.28 |
| Q4 2024 | -$0.34 | +$0.31 |
BFLY is still losing money, but far less than before: $0.21 per share over the past year, against $0.84 at its worst in late 2022.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over BFLY on earnings quality, reporting a profit while its opponent remains loss making.
BFLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.6M | +52% |
| Q2 2026 | $32.6M | +39% |
| Q1 2026 | $26.5M | +25% |
| Q4 2025 | $31.5M | +41% |
| Q3 2025 | $21.5M | +4.5% |
| Q2 2025 | $23.4M | +8.8% |
| Q1 2025 | $21.2M | +20% |
| Q4 2024 | $22.4M | +35% |
BFLY's revenue has grown year over year for 11 quarters in a row: $33M last quarter, up 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +122 points |
| Q2 2026 | -42% | +27 points |
| Q1 2026 | -52% | +35 points |
| Q4 2025 | -53% | +24 points |
| Q3 2025 | -164% | -80 points |
| Q2 2025 | -69% | +11 points |
| Q1 2025 | -87% | +41 points |
| Q4 2024 | -77% | +206 points |
BFLY's operating margin was −42% last quarter, up 122 points from the same quarter a year ago, near the top of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over BFLY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over BFLY on profitability, with a higher operating margin.
BFLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.4M | +$492K |
| Q2 2026 | -$17.2M | -$9.2M |
| Q1 2026 | -$14.8M | -$2.8M |
| Q4 2025 | $7.9M | +$11.5M |
| Q3 2025 | -$3.9M | +$4.4M |
| Q2 2025 | -$8.1M | +$2.7M |
| Q1 2025 | -$12M | +$9.8M |
| Q4 2024 | -$3.5M | +$12.1M |
BFLY has burned cash in almost every quarter: −$28M over the past year, against −$28M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over BFLY on cash generation, producing positive trailing cash flow while its opponent burns cash.
BFLY Net Leverage
BFLY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
BFLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 11.0 | Oversold |
BFLY's weekly RSI is 48 (neutral) and its Stochastic is 11 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
BFLY PE vs Healthcare Sector
BFLY has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
BFLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.50 | 11% below |
| 20 week MA | $7.71 | 13% below |
| 50 week MA | $5.72 | 17% above |
| 100 week MA | $4.12 | 62% above |
| 200 week MA | $2.87 | 132% above |
BFLY has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 132% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over BFLY on trend strength, trading above more of its moving averages.
BFLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $21.1 | +108% |
| 2021 | $21.1 | $7.39 | -65% |
| 2022 | $7.39 | $2.36 | -68% |
| 2023 | $2.36 | $1.08 | -54% |
| 2024 | $1.08 | $3.46 | +220% |
| 2025 | $3.46 | $3.85 | +11% |
| 2026 YTD | $3.85 | $6.67 | +73% |
BFLY has the edge over LLY on returns for 2026, with the stronger performance.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.